About 8 results found for searched term "Ganoderic acid T1" (0.122 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M41307 | Ganoderic acid T1 | Apoptosis |
| Ganoderic acid T1 is a deacetylated derivative of Ganoderic acid T. | ||
| M18527 | Ganoderic acid DM | Apoptosis |
| Ganoderic acid DM is a natural triterpenoid isolated from Ganoderma lucidum, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Ganoderic acid DM as a specific inhibitor of osteoclastogenesis. | ||
| M18578 | Ganoderic acid TR | Anti-infection |
| Ganoderic acid TR is a broad-spectrum inhibitor against influenza neuraminidases (NAs), particularly H5N1 and H1N1 neuraminidases with IC50 values of 10.9 and 4.6 μM, respectively. | ||
| M27817 | Ganoderic acid T-N | Anti-infection |
| T-N | ||
| Ganoderic acid T-N, a triterpenoid, is a H5N1 and H1N1 influenza neuraminidase (NA) inhibitor with IC50s of 2.7 μM and 42 μM, respectively. Ganoderic acid T-Q shows cytotoxicity against MCF7 cells (CC50=24.4 μM). | ||
| M28539 | Ganoderic acid AM1 | Others |
| GAAM1 | ||
| Ganoderic acid AM1 (GAAM1) is a natural product that can be found in ganoderma lucidum. Ganoderic acid AM1 shows cytotoxicity with an IC50 value of 19.8 µM for HeLa cells. | ||
| M30733 | Ganoderic acid Y | Glucosidase |
| Ganoderic acid Y is a α-glucosidase inhibitor with an IC50 of 170 μM for yeast α-glucosidase. Ganoderic acid Y inhibits enterovirus 71 (EV71) replication through blocking EV71 uncoating. | ||
| M38930 | Ganoderic acid T-Q | Microtubule |
| Ganoderic acid T-Q (Ganodermic acid T-Q) (compound 1) is a natural product that can be found in ganoderma lucidum. Ganoderic acid T-Q stimulates tubulin polymerization. | ||
| M44857 | Ganoderic acid GS-1 | HIV Protease |
| Ganoderic acid GS-1, a highly oxygenated lanostane-type triterpenoid, has anti-HIV-1 protease activities with an IC50 of 58 μM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
